BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6523302)

  • 1. Malignant melanoma and isolated limb perfusion.
    Giraud RM
    S Afr J Surg; 1984; 22(4):243-8. PubMed ID: 6523302
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolated limb perfusion for malignant melanoma.
    Rosin RD; Westbury G
    Practitioner; 1980 Oct; 224(1348):1031-6. PubMed ID: 7220430
    [No Abstract]   [Full Text] [Related]  

  • 3. [Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].
    Kettelhack C; Hohenberger P; Schlag PM
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():127-9. PubMed ID: 9101810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated regional limb hyperthermic perfusion as treatment for melanoma.
    Loescher LJ; Leigh S
    Cancer Nurs; 1984 Dec; 7(6):461-7. PubMed ID: 6568866
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolated limb perfusion for unresectable melanoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
    Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isolated extremity perfusion with tumor necrosis factor and melphalan.An option for treatment of satellite or in transit metastasis of malignant melanoma].
    Schlag PM; Kettelhack C
    Hautarzt; 1995 May; 46(5):361-2. PubMed ID: 7607905
    [No Abstract]   [Full Text] [Related]  

  • 8. [Regional hyperthermic perfusion has impressive effect on manifest malignant melanoma].
    Hafström L
    Lakartidningen; 1992 Sep; 89(39):3189-90. PubMed ID: 1405932
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolated limb perfusion for melanoma.
    Kroon BB; Noorda EM; Vrouenraets BC; van Slooten GW; Nieweg OE
    Surg Oncol Clin N Am; 2008 Oct; 17(4):785-94, viii-ix. PubMed ID: 18722918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated limb perfusion for malignant melanoma; possibly better results with high dose hyperthermia.
    Van der Zee J; Kroon BB
    Int J Hyperthermia; 2008 Nov; 24(7):602-3; author reply 604. PubMed ID: 18979311
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolated limb perfusion with high-dose tumor necrosis factor for extremity melanoma and sarcoma.
    Fraker DL; Alexander HR
    Important Adv Oncol; 1994; ():179-92. PubMed ID: 8206489
    [No Abstract]   [Full Text] [Related]  

  • 12. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion.
    Beasley GM; Petersen RP; Yoo J; McMahon N; Aloia T; Petros W; Sanders G; Cheng TY; Pruitt SK; Seigler H; Tyler DS
    Ann Surg Oncol; 2008 Aug; 15(8):2195-205. PubMed ID: 18528730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regional perfusion of the extremity - experience in 81 patients with malignant melanomas (author's transl)].
    Ghussen F; Groth W; Nagel K
    Z Hautkr; 1981 Jul; 56(14):911-20. PubMed ID: 7269716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective regression of unexcised melanoma in-transit metastases after hyperthermic isolation perfusion of the limbs with melphalan.
    Lejeune FJ; Deloof T; Ewalenko P; Fruhling J; Jabri M; Mathieu M; Nogaret JM; Verhest A
    Recent Results Cancer Res; 1983; 86():268-76. PubMed ID: 6648008
    [No Abstract]   [Full Text] [Related]  

  • 15. Results of regional hyperthermic perfusion for primary and recurrent melanomas of the extremities.
    Jönsson PE; Hafström L; Hugander A
    Recent Results Cancer Res; 1983; 86():277-82. PubMed ID: 6648009
    [No Abstract]   [Full Text] [Related]  

  • 16. Results of eleven years' experience with heated perfusion for melanoma of the extremities.
    Stehlin JS; Giovanella BC; de Ipolyi PD; Anderson RF
    Cancer Res; 1979 Jun; 39(6 Pt 2):2255-7. PubMed ID: 445425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regional hyperthermic perfusion in malignant melanoma of the extremities--controlled studies (proceedings)].
    Hafström L; Jönsson PE
    Lakartidningen; 1978 Dec; 75(49):4599-600. PubMed ID: 723351
    [No Abstract]   [Full Text] [Related]  

  • 19. Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor.
    Fraker DL; Alexander HR; Andrich M; Rosenberg SA
    Cancer J Sci Am; 1995; 1(2):122-30. PubMed ID: 9166465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermic perfusion in malignant melanoma: 5-year results.
    Tonak J; Hohenberger W; Weidner F; Göhl H
    Recent Results Cancer Res; 1983; 86():229-38. PubMed ID: 6648004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.